Dr.Kadam Diagnostic Centre Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 25-12-2024
- Paid Up Capital ₹ 0.12 M
as on 25-12-2024
- Company Age 37 Year,
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.20 M
as on 25-12-2024
- Satisfied Charges ₹ 9.55 M
as on 25-12-2024
- Revenue -17.29%
(FY 2021)
- Profit -43.75%
(FY 2021)
- Ebitda -48.49%
(FY 2021)
- Net Worth 9.44%
(FY 2021)
- Total Assets 12.74%
(FY 2021)
About Dr.Kadam Diagnostic Centre
The Corporate was formerly known as Dr Bhate-Kulkarni Diagnostic Centre Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹5.20 M. The company has closed loans amounting to ₹9.55 M, as per Ministry of Corporate Affairs (MCA) records.
Pranoti Kadam, Vijay Kadam, and Rishikesh Kadam serve as directors at the Company.
- CIN/LLPIN
U85195MH1987PTC045705
- Company No.
045705
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 1987
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr.Kadam Diagnostic Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranoti Kadam  | Director | 03-Mar-2006 | Current |
| Vijay Kadam | Director | 03-Mar-2006 | Current |
| Rishikesh Kadam | Director | 07-Feb-2022 | Current |
Financial Performance of Dr.Kadam Diagnostic Centre.
Dr.Kadam Diagnostic Centre Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 17.29% decrease. The company also saw a substantial fall in profitability, with a 43.75% decrease in profit. The company's net worth moved up by a moderate rise of 9.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Kadam Diagnostic Centre?
In 2021, Dr.Kadam Diagnostic Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Oct 2021 | ₹1.70 M | Open |
Hdfc Bank Limited Creation Date: 30 Oct 2018 | ₹1.50 M | Open |
Hdfc Bank Limited Creation Date: 09 Aug 2017 | ₹2.00 M | Open |
How Many Employees Work at Dr.Kadam Diagnostic Centre?
Dr.Kadam Diagnostic Centre has a workforce of 43 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Kadam Diagnostic Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Kadam Diagnostic Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
